Glen Santangelo
Stock Analyst at Barclays
(3.18)
# 1,140
Out of 5,147 analysts
127
Total ratings
50%
Success rate
0.95%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Maintains: Equal-Weight | $170 → $200 | $190.10 | +5.21% | 3 | Feb 26, 2026 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $48 → $25 | $14.52 | +72.18% | 6 | Feb 25, 2026 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $8 → $7 | $5.93 | +18.04% | 2 | Feb 25, 2026 | |
| OGN Organon & Co. | Maintains: Underweight | $7.5 → $8 | $7.29 | +9.74% | 2 | Feb 24, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $243 → $258 | $229.23 | +12.55% | 6 | Feb 24, 2026 | |
| MCK McKesson | Maintains: Overweight | $960 → $1,050 | $987.37 | +6.34% | 7 | Feb 18, 2026 | |
| HQY HealthEquity | Maintains: Overweight | $118 → $110 | $76.49 | +43.81% | 8 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $400 → $425 | $372.14 | +14.20% | 2 | Feb 13, 2026 | |
| NVST Envista Holdings | Maintains: Overweight | $24 → $34 | $29.21 | +16.40% | 3 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Overweight | $63 → $38 | $24.53 | +54.91% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $850 → $800 | $656.73 | +21.82% | 2 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $33.86 | +12.23% | 7 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $5.25 → $2.75 | $1.87 | +47.06% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $47.51 | +5.24% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $56 | $41.67 | +34.39% | 5 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $24 | $12.33 | +94.65% | 3 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $136 | $131.10 | +3.74% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $6.12 | +47.06% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $14.93 | +0.47% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8.5 | $5.26 | +61.60% | 8 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $75.52 | +32.42% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $3.5 | $4.82 | -27.39% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $29 | $17.69 | +63.93% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $16 | $12.56 | +27.39% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $21.91 | +23.23% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $82.39 | +4.38% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $26.40 | +13.64% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $14.68 | -18.26% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $73.90 | +35.32% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $20.23 | +48.29% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $13.81 | +8.62% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $37.98 | +29.02% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $3.99 | +25.31% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $25.65 | +98.83% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $5.47 | +1,728.15% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $91.68 | -40.01% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $1.62 | +1,628.40% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $5.70 | +2,005.26% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.28 | +2,712.50% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $79.90 | - | 3 | Mar 17, 2021 |
Align Technology
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $170 → $200
Current: $190.10
Upside: +5.21%
Hims & Hers Health
Feb 25, 2026
Maintains: Overweight
Price Target: $48 → $25
Current: $14.52
Upside: +72.18%
Bausch Health Companies
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $5.93
Upside: +18.04%
Organon & Co.
Feb 24, 2026
Maintains: Underweight
Price Target: $7.5 → $8
Current: $7.29
Upside: +9.74%
Cardinal Health
Feb 24, 2026
Maintains: Overweight
Price Target: $243 → $258
Current: $229.23
Upside: +12.55%
McKesson
Feb 18, 2026
Maintains: Overweight
Price Target: $960 → $1,050
Current: $987.37
Upside: +6.34%
HealthEquity
Feb 18, 2026
Maintains: Overweight
Price Target: $118 → $110
Current: $76.49
Upside: +43.81%
Cencora
Feb 13, 2026
Maintains: Overweight
Price Target: $400 → $425
Current: $372.14
Upside: +14.20%
Envista Holdings
Feb 11, 2026
Maintains: Overweight
Price Target: $24 → $34
Current: $29.21
Upside: +16.40%
Doximity
Feb 11, 2026
Maintains: Overweight
Price Target: $63 → $38
Current: $24.53
Upside: +54.91%
Feb 5, 2026
Maintains: Overweight
Price Target: $850 → $800
Current: $656.73
Upside: +21.82%
Jan 30, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $33.86
Upside: +12.23%
Jan 22, 2026
Downgrades: Hold
Price Target: $5.25 → $2.75
Current: $1.87
Upside: +47.06%
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $47.51
Upside: +5.24%
Jan 9, 2026
Maintains: Overweight
Price Target: $58 → $56
Current: $41.67
Upside: +34.39%
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $12.33
Upside: +94.65%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $131.10
Upside: +3.74%
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $6.12
Upside: +47.06%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $14.93
Upside: +0.47%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $5.26
Upside: +61.60%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $75.52
Upside: +32.42%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $4.82
Upside: -27.39%
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $17.69
Upside: +63.93%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $12.56
Upside: +27.39%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $21.91
Upside: +23.23%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $82.39
Upside: +4.38%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $26.40
Upside: +13.64%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $14.68
Upside: -18.26%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $73.90
Upside: +35.32%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $20.23
Upside: +48.29%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $13.81
Upside: +8.62%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $37.98
Upside: +29.02%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $3.99
Upside: +25.31%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $25.65
Upside: +98.83%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $5.47
Upside: +1,728.15%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $91.68
Upside: -40.01%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $1.62
Upside: +1,628.40%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $5.70
Upside: +2,005.26%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $1.28
Upside: +2,712.50%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $79.90
Upside: -